Abstract
Recent data from a series of laboratories has pinpointed the relevant role of translation control on the regulation of gene expression. In particular, an analysis of T cell activation has led to demonstrate that during this physiological transition about 20% of the regulated mRNAs are controlled at the translation level. Furthermore, modulating the host mRNA translation is one of the mechanisms used by infectious agents to achieve a productive infection. In the present review, we summarize the current knowledge on the translation machinery, the translational control mechanisms during the immune response, as well as the mechanisms used by different pathogens to avoid, inhibit or postpone the host response; and suggest that the analysis on genome-wide screening of the host-pathogen interactions, identifying translationally regulated mRNAs, might unravel new drug targets in infectious diseases.
Keywords: Infectious Diseases, mRNAs, translation control, T cell, immune response, host-pathogen interactions, drug targets
Infectious Disorders - Drug Targets
Title: Translation Controlled mRNAs: New Drug Targets in Infectious Diseases?
Volume: 8 Issue: 4
Author(s): Eva Diaz-Guerra, Rolando Vernal, Walter Cantero, Ernst W. Mullner and Jose A. Garcia- Sanz
Affiliation:
Keywords: Infectious Diseases, mRNAs, translation control, T cell, immune response, host-pathogen interactions, drug targets
Abstract: Recent data from a series of laboratories has pinpointed the relevant role of translation control on the regulation of gene expression. In particular, an analysis of T cell activation has led to demonstrate that during this physiological transition about 20% of the regulated mRNAs are controlled at the translation level. Furthermore, modulating the host mRNA translation is one of the mechanisms used by infectious agents to achieve a productive infection. In the present review, we summarize the current knowledge on the translation machinery, the translational control mechanisms during the immune response, as well as the mechanisms used by different pathogens to avoid, inhibit or postpone the host response; and suggest that the analysis on genome-wide screening of the host-pathogen interactions, identifying translationally regulated mRNAs, might unravel new drug targets in infectious diseases.
Export Options
About this article
Cite this article as:
Diaz-Guerra Eva, Vernal Rolando, Cantero Walter, Mullner W. Ernst and Garcia- Sanz A. Jose, Translation Controlled mRNAs: New Drug Targets in Infectious Diseases?, Infectious Disorders - Drug Targets 2008; 8 (4) . https://dx.doi.org/10.2174/187152608786734205
DOI https://dx.doi.org/10.2174/187152608786734205 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bioaccessibility of Bioactive Compounds and Prebiotic Properties of Fruit and Vegetable By-products - A Mini Review
Current Bioactive Compounds Coumarin and Derivates as Lipid Lowering Agents
Current Topics in Medicinal Chemistry Prevention of Non-communicable Diseases by Balanced Nutrition: Population- specific Effective Public Health Approaches in Developing Countries
Current Diabetes Reviews Drug-Resistant Epilepsy and Surgery
Current Neuropharmacology Regulation of Drug Metabolism and Transporters
Current Drug Metabolism Carbon Monoxide in Acute Lung Injury
Current Pharmaceutical Biotechnology Self-Assembled Nanoparticles of Natural Phytochemicals (Berberine and 3,4,5-Methoxycinnamic Acid) Originated from Traditional Chinese Medicine for Inhibiting Multidrug-Resistant <i>Staphylococcus aureus</i>
Current Drug Delivery Stress and the α7 Nicotinic Acetylcholine Receptor
Current Drug Targets Global Life-Long Health Benefits of Repression of Hypothalamic NPY System by Central Leptin Gene Therapy
Current Topics in Medicinal Chemistry Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Current Pharmacogenomics Abnormal Saccadic Intrusions with Alzheimer's Disease in Darkness
Current Alzheimer Research Prediction of the Disordered Regions of Intrinsically Disordered Proteins Based on the Molecular Functions
Protein & Peptide Letters Deletion of Endoplasmic Reticulum Stress-Induced CHOP Protects Microvasculature Post-Spinal Cord Injury
Current Neurovascular Research Selective Androgen Receptor Modulators Antagonize Apolipoprotein E4-Induced Cognitive Impairments
Letters in Drug Design & Discovery Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism
Current Pharmaceutical Design Antiepileptogenic Effect of Retinoic Acid
Current Neuropharmacology Evaluation of the Effects of a New Drug on Brain Leukocyte Infiltration in an Experimental Model of Autoimmune Encephalomyelitis
Letters in Drug Design & Discovery Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
Current Alzheimer Research Pharmacophore-based Screening for Identification of Human Acyl-CoA Cholesterol Acyltransferase Inhibitors: An In-silico Study
Letters in Drug Design & Discovery Comparative Analysis of In Vitro Rat Liver Metabolism of the Antimalarial Primaquine and a Derived Imidazoquine
Drug Metabolism Letters